Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Capecitabine | 154361-50-9 | 99.99% | C15H22FN3O6 | 1 ML
Supplier: Medchemexpress LLC HYB001610MM/1ML
Capecitabine is an oral proagent that converts to its active metabolite, 5-FU, via thymidine phosphorylase. It is an anti-cancer chemotherapy drug, classified as an antimetabolite. Capecitabine is converted into 5′-deoxy-5-fluorocytidine (5′DFCR), 5′-deoxy-5-fluorouridine (5′DFUR), and 5-FU by carboxylesterases (CES1 and 2), cytidine deaminase (CDD), and thymidine phosphorylase (TP) in both the liver and tumor. Capecitabine induces a significant cytotoxic effect in vitro only at high concentrations.
- Intended for research use only
- Converted to active metabolite, 5-FU, in the liver and tumor
- Classified as an antimetabolite
- Induces cytotoxic effect in vitro at high concentrations
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?